American Century Companies’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ORMP
AF
GIA
BCM
RG
VPM
American Century Companies's ORMP Position: Q2 2026 in Review
American Century Companies increased its Oramed Pharmaceuticals (ORMP) stake by 85% in Q2 2026, buying an estimated $109K and bringing the position to 59,775 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #2709.
American Century Companies first reported a position in ORMP in Q2 2023 and has held it in 13 quarters since. 57 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.
- American Century Companies held 59,775 shares of Oramed Pharmaceuticals worth $288K as of Q2 2026.
- American Century Companies bought 27,468 Oramed Pharmaceuticals shares in Q2 2026, an estimated $109K.
- Oramed Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2709 holding.
- American Century Companies first reported a position in Oramed Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
- 57 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.